OM2 Low Saturation Verification

Inclusion Criteria:

1. Healthy volunteers 18 to ≤39 years

2. Subject is willing and able to comply with study procedures and duration

3. Subject is willing to sign an informed consent

4. Subject weighs >40kg

5. Subject is a non-smoker or has not smoked within 2 days prior to the study

6. Cleared same day health assessment form and health screening

Exclusion Criteria:

1. Subject is considered as being morbidly obese (defined as BMI >39.5)

2. Compromised circulation, injury, or physical malformation of fingers, hands, ears orforehead/skull or other sensor sites which would limit the ability to test sitesneeded for the study (Note: Certain malformations may still allow subjects toparticipate if the condition is noted and would not affect the sites utilized)

3. Subjects of childbearing potential who are pregnant, who are trying to get pregnant,or who have a urine test positive for pregnancy on the day of the study

4. Subjects with known concurrent, active respiratory conditions such as:

5. uncontrolled / severe asthma

6. flu or influenza type infection

7. pneumonia / bronchitis

8. shortness of breath / respiratory distress

9. unresolved respiratory or lung surgery

10. emphysema, COPD, lung disease

11. recent COVID (last 2 months)

12. Subjects with known heart or cardiovascular conditions such as:

13. hypertension: systolic >140mmHg, or Diastolic >90mmHg on 3 consecutive readings

14. have had cardiovascular surgery

15. chest pain (angina)

16. heart rhythms other than a normal sinus rhythm and/or with respiratory sinusarrhythmia, at the discretion of the Principal Investigator or designee

17. previous heart attack

18. blocked artery

19. unexplained shortness of breath

20. congestive heart failure (CHF)

21. history of stroke

22. transient ischemic attack

23. carotid artery disease

24. myocardial ischemia

25. myocardial infarction

26. cardiomyopathy

27. implantable active medical device such as pacemaker or automatic defibrillator

28. Self-reported health conditions as identified in the Health Assessment Form

29. diabetes

30. uncontrolled thyroid disease

31. kidney disease / chronic renal impairment

32. history of seizures (except childhood febrile seizures)

33. epilepsy

34. history of unexplained syncope

35. recent history of frequent migraine headaches

36. recent symptomatic head injury, within the last 2 months

37. cancer requiring chemotherapy, radiation, or current treatment

38. subjects with known clotting disorders

39. history of bleeding disorders or personal history of prolonged bleeding frominjury

40. history of blood clots

41. hemophilia

42. sickle cell trait or disease

43. current use of blood thinner: prescription or daily use such as aspirin

44. subjects with Severe contact allergies to standard adhesives, latex or othermaterials found in pulse oximetry sensors, ECG electrodes, respiration monitorelectrodes or other medical sensors

45. participants with severe allergy to iodine (only applicable if iodine is used)

46. subjects with prior or known severe allergies to lidocaine (or similarpharmacological agents, e.g. Novocain) or heparin

47. arterial cannulation within the last 30 days prior to study date, (this mayexclude only one radial artery site, left or right)

48. history of clinically significant complications from previous arterialcannulation

49. unwillingness or inability to remove colored nail polish or colored artificialnails other than clear from test digits

50. other known health condition, upon disclosure in Health Assessment form